Document Type
Article
Publication Date
11-1-2022
Abstract
Vascular imaging with color and power Doppler is a useful tool in the assessment of various disease processes. Assessment of blood flow, from infarction and ischemia to hyperemia, in organs, neoplasms, and vessels, is used in nearly every US investigation. Recent developments in this area are sensitive to small-vessel low velocity flow without use of intravenous contrast agents, known as microvascular flow imaging (MVFI). MVFI is more sensitive in detection of small vessels than color, power, and spectral Doppler, reducing the need for follow-up contrast-enhanced US (CEUS), CT, and MRI, except when arterial and venous wash-in and washout characteristics would be helpful in diagnosis. Varying clinical applications of MVFI are reviewed in adult and pediatric populations, including its technical underpinnings. MVFI shows promise in assessment of several conditions including benign and malignant lesions in the liver and kidney, acute pathologic abnormalities in the gallbladder and testes, and superficial lymph nodes. Future potential of MVFI in different conditions (eg, endovascular repair) is discussed. Finally, clinical cases in which MVFI correlated and potentially obviated additional CEUS, CT, or MRI are shown.
Recommended Citation
Aziz, Muhammad Usman; Eisenbrey, John R; Deganello, Annamaria; Zahid, Mohd; Sharbidre, Kedar; Sidhu, Paul; and Robbin, Michelle L, "Microvascular Flow Imaging: A State-of-the-Art Review of Clinical Use and Promise." (2022). Department of Radiology Faculty Papers. Paper 135.
https://jdc.jefferson.edu/radiologyfp/135
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.
PubMed ID
36165794
Language
English
Comments
This article is the author's final published version in Radiology, Volume 305, Issue 2, November 2022, Pages 250 - 264.
The published version is available at https://doi.org/10.1148/radiol.213303.
Copyright © RSNA, 2022.